|
Prudential and Babylon Join Forces to Pioneer AI-Powered Digital Health Services in Asia
Providing Accessible and Affordable Healthcare across Asia
HONG KONG / LONDON, Aug 02, 2018 - (Media OutReach) - Prudential Corporation Asia ("Prudential") (2378.HK) today announced it has entered into an exclusive partnership agreement with UK-based healthcare technology and services company Babylon Health ("Babylon")[1]. Babylon's artificial intelligence ("AI") expertise will be made available to existing and new customers of Prudential across Asia marking a step change in Prudential's commitment to provide digital health services making healthcare affordable and accessible across Asia.
Prudential is a leading provider of medical insurance in Asia, with over five million health customers and premium income exceeding GBP800 million in 2017. Based in the UK, Babylon offers a world-leading suite of AI-powered health services, including personal health assessment and treatment information, empowering users to proactively manage their health. Through the deployment of cutting-edge AI technology, the Prudential-Babylon proposition will offer customers in up to 12 markets in Asia 24/7 access to a comprehensive set of digital health tools, complementing Prudential's existing suite of world-class protection products.
Nic Nicandrou, Chief Executive of Prudential Corporation Asia, said: "At Prudential, we strive to help customers lead healthier and more secure lives. The strategic partnership with Babylon is consistent with our ambition to address the unmet healthcare needs in Asia where the majority of the population are uninsured or underinsured, alongside an ageing population and escalating medical costs. This partnership accelerates our efforts to provide customer-centric, cost efficient and scalable health and wellness digital services to customers in the region."
"We are significantly expanding our role from protection to encompass the prevention and postponement of adverse health events. By empowering customers with self-help tools and real-time health information, we believe the Babylon-enabled platform will inspire them to take an active role in understanding and managing their current and future health needs. Prudential remains committed to help both consumers and governments find efficient solutions to expand access to quality healthcare across Asia."
Dr Ali Parsa, Babylon's Founder & CEO, said: "Prudential is one of Asia's leading insurance providers, where its brand is synonymous with trust. We find it humbling that after a lengthy search, Prudential's forward-looking leadership has put its trust in Babylon as its partner. Both organisations share the same mission, which is to make healthcare accessible and affordable to everyone on Earth. We look forward to working with one of the most innovative leadership teams in insurance, as they work to build on their strong legacy in Asia and continue in their contribution of enhancing the well-being of its people."
Market-specific details and launch dates for Prudential's Babylon-enabled health services will be announced later in the year.
ABOUT PRUDENTIAL CORPORATION ASIA
Prudential Corporation Asia is a business unit of Prudential plc (United Kingdom), comprising its life insurance operations in Asia, and its asset management business, Eastspring Investments. It is headquartered in Hong Kong.
Prudential is a leading life insurer that spans 12 markets in Asia, covering Cambodia, China, Hong Kong, India, Indonesia, Laos, Malaysia, the Philippines, Singapore, Taiwan, Thailand and Vietnam. Prudential has a robust multi-channel distribution platform providing a comprehensive range of savings, investment and protection products to meet the diverse needs of Asian families.
Eastspring Investments manages investments across Asia on behalf of a wide range of retail and institutional investors. It is one of the region's largest asset managers, with a presence in 10 major Asian markets plus distribution offices in the US and Europe. It has GBP139 billion (c. US$188 billion) in assets under management (as at 31 December 2017), managing funds across a range of asset classes including equities and fixed income.
For more information, please visit: www.prudentialcorporation-asia.com
ABOUT PRUDENTIAL PLC
Prudential plc is incorporated in England and Wales, and its affiliated companies constitute one of the world's leading financial services groups. It provides insurance and financial services through its subsidiaries and affiliates throughout the world. It has been in existence for 170 years and has GBP669 billion in assets under management (as at 31 December 2017). Prudential plc is not affiliated in any manner with Prudential Financial, Inc, a company whose principal place of business is in the United States of America.
Prudential plc is listed on the stock exchanges of London (PRU.L), Hong Kong (2378.HK), Singapore (K6S.SG) and New York (PUK.N).
ABOUT BABYLON HEALTH
Babylon's mission is to put an accessible and affordable health service in the hands of every person on earth. Babylon uses a combination of cutting-edge AI technology and the best available medical expertise to deliver 24-hours-a-day, 7-days-a-week access to digital health tools (including health assessment, triage and health tools), with over 3 million members across Europe, North America, Asia, the Middle East and Africa, as well as video doctor consultations.
For more information, please visit: www.babylonhealth.com
MEDIA CONTACTS
Prudential Corporation Asia Susanna Hui Tel: +852 2918 5485 Email: susanna.hui@prudential.com.hk
Ee Ching Tan Tel: +852 2918 6396 Email: ee.ching.tan@prudential.com.hk
Babylon Babylon Press Team Email: press@babylonhealth.com
For Babylon-related videos, photographs and logos, please visit: https://www.babylonhealth.com/press/press-centre
[1] Exclusivity is in respect of up to 12 health, life and pension markets in Asia.
Source: Prudential
Copyright ©2026 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
|
Latest Release
 Honda Makes Gachaco a Consolidated Subsidiary by Subscribing to New Shares of Gachaco Issued Through Third-party Allotment
Apr 01, 2026 22:09 JST
|  DENSO Hosted "DENSO DIALOG DAY 2026", Delivers Mid-Term Management Plan "CORE 2030" Apr 01, 2026 21:54 JST
|  MHI President Eisaku Ito Offers Words of Encouragement to New Employees at the Company's 2026 Welcoming Ceremony Apr 01, 2026 13:35 JST
|  MHI Completes the Transfer Procedures for its Domestic Onshore Wind Power Business Apr 01, 2026 13:26 JST
|  Toyota Motor Corporation aims to join Daimler Truck and Volvo Group as equal shareholder in the fuel cell joint venture cellcentric Mar 31, 2026 23:39 JST
|  Honda Announces the Establishment of PathAhead Co., Ltd., a Startup Originated from IGNITION, a Honda New Business Creation Program Mar 31, 2026 21:58 JST
|  Hitachi Digital Services Strengthens OT-IT Integration with Manufacturing Operations Management Platform Mar 31, 2026 19:14 JST
|  Fujitsu and Osaka University of Health and Sport Sciences partner to innovate sports performance with skeleton recognition AI Mar 31, 2026 17:42 JST
|  DOCOMO and SK Telecom Publish White Paper on Requirements for Advancing vRAN and AI-RAN in Mobile Networks Mar 31, 2026 11:00 JST
|  NEC Supports Ooredoo Algeria in Modernizing Enterprise Network Security with high-performance next-generation firewalls (NGFW) Mar 31, 2026 10:50 JST
|  MOL and Hitachi Launch Initiative to Convert Used Ships into Floating Data Centers Mar 30, 2026 19:21 JST
|  Resona Holdings, BrainPad, and Fujitsu sign basic agreement for collaboration to transform financial operations with data and AI and advance next-generation data utilization Mar 30, 2026 15:55 JST
|  MHI Innovative Combustion Dynamics Laboratory is Established at Kyoto University with the Aim of Developing and Socially Implementing World-Leading Technology Mar 30, 2026 12:53 JST
|  Fujitsu launches generative AI service that analyzes source code and automatically generates design documents Mar 30, 2026 10:41 JST
|  Application Submitted for LENVIMA(R) (lenvatinib) in Japan Seeking Approval of Additional Dosage and Administration for Combination with WELIREG(R) (belzutifan) for Renal Cell Carcinoma that has Progressed After Chemotherapy Mar 27, 2026 20:14 JST
|  Hitachi and MUFG Bank expand NextGen model to finance vehicles and charging infrastructure for decarbonized mobility Mar 27, 2026 19:44 JST
|  Eisai and Nuvation Bio Announce Marketing Authorisation Application for Taletrectinib for the Treatment of Advanced ROS1-Positive Non-Small Cell Lung Cancer Validated by the European Medicines Agency Mar 27, 2026 18:19 JST
|  New "L00 Series" Train for the Seibu Railway's Yamaguchi Line Begins Commercial Operation Mar 27, 2026 16:51 JST
|  Fujitsu develops high-sensitivity, high-resolution infrared sensor to expand monitoring capabilities in defense and disaster prevention Mar 27, 2026 14:07 JST
|  Sharp Develops Long-Range Video Monitoring Technology Mar 26, 2026 22:39 JST
|
More Latest Release >>
|